Lexibulin hydrochloride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLexibulin hydrochloride
Drug Alias Namelexibulina来西布林盐酸盐盐酸来西布林lexibuline来昔布林盐酸盐 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitors
TargetsTubulin
Therapy Area/IndicationsMultiple MyelomaGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Sciences Inc
Active IndicationsN/A
Inactive IndicationsMultiple MyelomaGlioblastoma

Other Information

ATC CodeN/A
Related LinksKEGG